List of insiders holdings for CODEXIS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Shell Brazil Holding B.V. 10% Owner |
2011-06-02 09:19:13 | 11,146,638 0 |
11,146,638 | Form 4 |
2 | Equilon Enterprises LLC 10% Owner |
2011-05-24 11:17:40 | 11,146,638 0 |
11,146,638 | Form 4 |
3 | Opaleye Management Inc. 10% Owner |
2025-04-17 18:07:35 | 0 9,855,000 |
9,855,000 | Form 4 |
4 | SULAT JAMES R Director 10% Owner |
2010-04-29 21:44:56 | 30,816 5,957,108 |
5,987,924 | Form 4 |
5 | MAXYGEN INC 10% Owner |
2010-12-17 09:38:27 | 5,969,917 0 |
5,969,917 | Form 4 |
6 | Raizen Energia Participacoes S.A. Ispagnac Participacoes Ltda. Royal Dutch Shell plc Cosan S.A. Industria e Comercio Cosan Ltd. 10% Owner |
2011-06-07 16:50:48 | 5,573,319 0 |
5,573,319 | Form 13D |
7 | Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. VIVO VENTURES VII LLC 10% Owner |
2019-02-14 15:18:59 | 2,620,530 0 |
2,620,530 | Form 13G |
8 | DILLY STEPHEN GEORGE See Remarks |
2025-02-07 20:15:52 | 1,205,553 0 |
1,205,553 | Form 4 |
9 | NICOLS JOHN J Director |
2023-04-19 16:18:46 | 1,105,391 0 |
1,105,391 | Form 4 |
10 | Ryali Sriram Chief Financial Officer |
2024-01-02 21:24:26 | 489,916 0 |
489,916 | Form 4 |
11 | Fitzgerald Margaret Nell See Remarks |
2024-01-02 21:23:56 | 447,895 0 |
447,895 | Form 4 |
12 | Norrett Kevin Chief Operating Officer |
2025-02-07 20:20:55 | 338,577 0 |
338,577 | Form 4 |
13 | MOORE ALISON Chief Technical Officer |
2025-02-07 20:18:24 | 336,821 0 |
336,821 | Form 4 |
14 | SHAW ALAN President and CEO |
2011-12-19 17:41:20 | 75,000 202,000 |
277,000 | Form 4 |
15 | Sheehy Douglas T. See Remarks |
2016-03-08 18:46:01 | 247,617 0 |
247,617 | Form 4 |
16 | Erbez Georgia Chief Financial Officer |
2025-02-07 20:17:12 | 238,125 0 |
238,125 | Form 4 |
17 | SANGSTER GORDON SVP & Chief Financial Officer |
2019-03-22 18:25:08 | 235,453 0 |
235,453 | Form 4 |
18 | Dorgan Byron L Director |
2024-06-13 18:25:59 | 223,581 0 |
223,581 | Form 4 |
19 | KELLEY BERNARD J Director |
2021-08-12 16:13:46 | 206,136 0 |
206,136 | Form 4 |
20 | Aldridge Michael D. See Remarks |
2018-05-18 17:54:46 | 206,000 0 |
206,000 | Form 4 |
21 | Seufer-Wasserthal Peter SVP, Pharmaceuticals |
2013-01-28 21:25:24 | 158,950 0 |
158,950 | Form 4 |
22 | Smith David V Director |
2024-06-13 18:28:42 | 64,722 88,570 |
153,292 | Form 4 |
23 | Sarret Joseph J. SVP and CBO |
2012-03-09 19:42:44 | 133,000 13,333 |
146,333 | Form 4 |
24 | Lalonde James SVP, R&D |
2019-05-15 16:23:02 | 135,780 0 |
135,780 | Form 4 |
25 | O'Toole David D SVP & Chief Financial Officer |
2013-09-06 19:14:06 | 110,687 0 |
110,687 | Form 4 |
26 | WOLF DENNIS P Director |
2024-06-13 18:28:11 | 106,920 0 |
106,920 | Form 4 |
27 | PARKER H STEWART Director |
2024-06-13 18:27:38 | 102,600 0 |
102,600 | Form 4 |
28 | Singhvi Rahul Director |
2024-06-13 18:27:54 | 96,069 0 |
96,069 | Form 4 |
29 | Anton David L. SVP, BioIndustrials |
2013-02-12 21:23:02 | 93,777 0 |
93,777 | Form 4 |
30 | Martinborough Esther Director |
2024-06-13 18:26:11 | 88,053 0 |
88,053 | Form 4 |
31 | Tobin Matthew SVP, Research & Development |
2013-05-17 21:03:59 | 78,707 0 |
78,707 | Form 4 |
32 | Karsner Alexander Director |
2014-01-06 18:15:46 | 78,519 0 |
78,519 | Form 4 |
33 | Collins Cynthia Director |
2025-04-01 12:39:38 | 71,174 0 |
71,174 | Form 4 |
34 | Cheng Pam P. Director |
2019-06-13 16:11:26 | 69,589 0 |
69,589 | Form 4 |
35 | Glaub Kathleen Sereda Director |
2019-06-13 16:12:42 | 68,481 0 |
68,481 | Form 4 |
36 | Aaker Jennifer Director |
2023-06-15 16:11:01 | 66,211 0 |
66,211 | Form 4 |
37 | Strumph Peter M Interim President and CEO |
2012-06-05 18:14:33 | 60,756 0 |
60,756 | Form 4 |
38 | Yang Patrick Y Director |
2022-06-16 16:14:10 | 53,785 0 |
53,785 | Form 4 |
39 | De Vre Raymond Director |
2024-11-12 16:29:58 | 47,846 0 |
47,846 | Form 4 |
40 | Richards Christos Director |
2025-01-16 18:28:33 | 44,150 0 |
44,150 | Form 4 |
41 | Lawson Robert J SVP and CFO |
2011-05-12 21:26:48 | 44,000 0 |
44,000 | Form 4 |
42 | TAYLOR DEAN ROSS JR Advisor |
2023-02-09 16:21:47 | 38,554 0 |
38,554 | Form 4 |
43 | Ho Mark Principal Accounting Officer |
2012-07-17 18:20:54 | 34,090 0 |
34,090 | Form 3 |
44 | BARUCH THOMAS R Director |
2020-06-16 16:03:50 | 33,093 0 |
33,093 | Form 4 |
45 | Dowd Brian Paul Interim CFO |
2012-06-05 18:14:18 | 28,310 0 |
28,310 | Form 4 |
46 | Pasternack Bruce A Director |
2010-08-27 21:11:28 | 10,000 0 |
10,000 | Form 4 |
47 | Streng Chris Director |
2010-04-21 20:37:41 | 0 0 |
0 | Form 3 |
48 | Mizutani Pedro Isamu Director |
2011-07-22 17:33:44 | 0 0 |
0 | Form 3 |
49 | Wong Mun Yew Director |
2010-04-29 21:49:01 | 0 0 |
0 | Form 4 |
50 | CMEA VENTURES LIFE SCIENCES 2000 LP CMEA Ventures Life Sciences 2000 Civil Law Partnership CMEA Ventures LS Management 2000 L.P. Collier David J Handelsman Karl D. Director 10% Owner |
2014-11-12 16:31:56 | 0 0 |
0 | Form 4 |
51 | Biomedical Sciences Investment Fund Pte Ltd. EDB Investments Pte Ltd. 10% Owner |
2018-02-12 06:08:14 | 0 0 |
0 | Form 13G |